Cargando…

Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma

PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Y., Zhao, Y., Chen, K., Shen, J., Shi, J., Lu, S., Lei, J., Li, Z., Luo, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394766/
https://www.ncbi.nlm.nih.gov/pubmed/29876836
http://dx.doi.org/10.1007/s40618-018-0908-y
_version_ 1783398965192949760
author Luo, Y.
Zhao, Y.
Chen, K.
Shen, J.
Shi, J.
Lu, S.
Lei, J.
Li, Z.
Luo, D.
author_facet Luo, Y.
Zhao, Y.
Chen, K.
Shen, J.
Shi, J.
Lu, S.
Lei, J.
Li, Z.
Luo, D.
author_sort Luo, Y.
collection PubMed
description PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with cervical lymph node metastasis. ROC analysis was used to determine the ideal critical points of the sum of the maximum diameter of multifocal in a unilateral lobe. RESULTS: The probability of LNM, central lymph node metastasis (CLNM) and lateral lymph node metastasis(LLNM)of PTMC patients were 35.6, 33.7 and 5.6%, respectively. In addition, 1.9% PTMC had LLNM only. Male, age ≤ 40 years, tumor largest diameter ≥ 5 mm, multifocal, non-uniform echoic distribution, the sum of the maximum diameter of multifocal in a unilateral lobe ≥ 8.5 mm, tumors in the lower pole location were prone to CLNM. Ultrasound mix-echo, the sum of the maximum diameter of the multifocal ≥ 10.75 mm, tumors in the upper pole location were extremely prone to LLNM. T3 were prone to LLNM or skip LLNM. CONCLUSIONS: According to the clinicopathological characteristics of PTMC, the cervical lymph nodes should be correctly evaluated to guide the surgical treatment.
format Online
Article
Text
id pubmed-6394766
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-63947662019-03-15 Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma Luo, Y. Zhao, Y. Chen, K. Shen, J. Shi, J. Lu, S. Lei, J. Li, Z. Luo, D. J Endocrinol Invest Original Article PURPOSE: Lymph node metastasis (LNM) is a vital prognosis factor in patients with papillary thyroid microcarcinoma (PTMC). The study tried to identify clinicopathological factors for LNM of PTMC. METHODS: The clinicopathological data of 1031 patients with PTMC were extracted and analyzed. Univariate and multivariate analyses were used to identify risk factors associated with cervical lymph node metastasis. ROC analysis was used to determine the ideal critical points of the sum of the maximum diameter of multifocal in a unilateral lobe. RESULTS: The probability of LNM, central lymph node metastasis (CLNM) and lateral lymph node metastasis(LLNM)of PTMC patients were 35.6, 33.7 and 5.6%, respectively. In addition, 1.9% PTMC had LLNM only. Male, age ≤ 40 years, tumor largest diameter ≥ 5 mm, multifocal, non-uniform echoic distribution, the sum of the maximum diameter of multifocal in a unilateral lobe ≥ 8.5 mm, tumors in the lower pole location were prone to CLNM. Ultrasound mix-echo, the sum of the maximum diameter of the multifocal ≥ 10.75 mm, tumors in the upper pole location were extremely prone to LLNM. T3 were prone to LLNM or skip LLNM. CONCLUSIONS: According to the clinicopathological characteristics of PTMC, the cervical lymph nodes should be correctly evaluated to guide the surgical treatment. Springer International Publishing 2018-06-06 2019 /pmc/articles/PMC6394766/ /pubmed/29876836 http://dx.doi.org/10.1007/s40618-018-0908-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Luo, Y.
Zhao, Y.
Chen, K.
Shen, J.
Shi, J.
Lu, S.
Lei, J.
Li, Z.
Luo, D.
Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title_full Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title_fullStr Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title_full_unstemmed Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title_short Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
title_sort clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394766/
https://www.ncbi.nlm.nih.gov/pubmed/29876836
http://dx.doi.org/10.1007/s40618-018-0908-y
work_keys_str_mv AT luoy clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT zhaoy clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT chenk clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT shenj clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT shij clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT lus clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT leij clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT liz clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma
AT luod clinicalanalysisofcervicallymphnodemetastasisriskfactorsinpatientswithpapillarythyroidmicrocarcinoma